AI in Dentistry: The 2026 State of Play
AI in dentistry has moved from pilot projects to cleared clinical tools. Here's what's real, what's regulatory, and what still needs work.
AI-assisted, human-governed and fact-checked — how we work.
Produced with AI assistance under human editorial governance and fact-checked against the cited sources. How we work.
AI in dentistry has crossed the line from research curiosity to billable clinical tool — but the gap between the best implementations and the average practice’s experience is still wide. Here’s an honest account of where things stand.
The Investment Surge Is Real, and So Is the Hype
In 2024, Pearl closed a $58 million Series B round and Overjet followed with $53 million in Series C funding — the two largest fundraises in dental AI history, per Dental Economics. The global market sits at roughly $421 million today; analysts expect it to surpass $3 billion by 2034, expanding at a compound annual rate of around 27%.
Those numbers get cited constantly in vendor decks, and they’re not wrong. But they also reflect how much money is chasing a still-maturing technology. Not every product that ships this year will still be shipping in 2028. Practices evaluating dental ai software should look for FDA clearance and peer-reviewed validation first — market size projections second.
What FDA Clearance Actually Covers
A 2025 narrative review found 13 companies offering 29 FDA-cleared AI products specifically for dental imaging, spanning caries detection, periodontal assessment, cephalometric analysis, multi-pathology diagnostics, automated charting, and 3D segmentation. Most of these cleared the FDA under the 510(k) Premarket Notification pathway, which applies to moderate-risk devices.
One exception worth noting: DentalMonitoring received a De Novo approval — a higher-level regulatory designation for genuinely novel device types — from the FDA in May 2024 for its AI-powered remote orthodontic monitoring platform. That’s a meaningful distinction, not just marketing language.
Clearance matters because it establishes a legal baseline, but it doesn’t tell you how a product performs in your patient mix, on your imaging hardware, with your radiographic technique. Those variables still require clinical judgment.
Where the Diagnostic Evidence Is Strongest
Radiographic detection is where the evidence is most mature. A systematic review of diagnostic AI in dentistry (see sources) documents that AI tools have achieved high accuracy for identifying caries and periodontal disease on panoramic radiographs, with some peer-reviewed studies reporting figures exceeding 90% — though results vary meaningfully by dataset composition, annotation method, and imaging hardware. According to VideaHealth’s own published data, their platform helped reduce the number of caries lesions clinicians missed by 43% and cut incorrect diagnoses by roughly 15%. That’s a meaningful number — especially for less experienced clinicians, where studies have shown AI support significantly improves identification of periapical radiolucency.
Orthodontics is the most studied dental discipline in the AI literature, per a bibliometric analysis covering at least 16 distinct AI task types. According to research cited in peer-reviewed literature on diagnostic AI in dentistry, AI models have shown promising accuracy for predicting orthodontic treatment outcomes in standard cases, which helps with planning timelines and setting realistic expectations. According to DEXIS AI, the company analyzed more than 120 million clinical findings in 2025 alone — a figure drawn from the manufacturer’s own reporting.
Generative AI is the newer frontier. Research published in 2025 shows promising early applications in crown design, automated dental charting, and educational content generation — using generative adversarial networks, diffusion models, and large language models. The clinical use cases are real, though most are still years away from routine practice. For a closer look at how specific platforms are stacking up in diagnostic imaging, see our comparison of overjet dental ai and our deep-dive on pearl ai dental.
The Standards Gap Is Being Addressed — Slowly
For years, one of the biggest credibility problems in dental AI was the absence of agreed-upon methodology. Two tools could both claim “high accuracy” for caries detection while using completely different datasets, annotation protocols, and statistical thresholds.
That’s starting to change. In early 2025, ANSI/ADA Standard No. 1110-1:2025 was approved — the first U.S. standard specifically governing AI in dentistry. It establishes standardized criteria for annotating and collecting data from 2D radiographs for use in clinical decision-making. The ADA’s complementary Technical Report No. 1109:2025 goes further, recommending an independent, third-party-held dataset to allow developers, users, and regulators to benchmark algorithm accuracy and specificity against a common standard.
This is genuinely useful progress. Independent validation datasets are exactly what the field needs if practices are going to make meaningful comparisons between products.
In Europe, dental AI systems now fall under the EU AI Act (2024), which classifies medical diagnostic AI as high-risk and requires transparency disclosures, human oversight mechanisms, and conformity assessments. Practices operating in multiple jurisdictions should be paying attention to this.
The Adoption Reality
The challenges aren’t primarily technical anymore. They’re organizational. Research consistently identifies small sample sizes, methodological inconsistency across studies, and the difficulty of integrating AI into clinical workflows as the main friction points. Clinicians who’ve adopted diagnostic AI tools generally report that the technology helps catch things — but only when it’s embedded in a workflow where someone is actually looking at its output.
Longer term, as AI matures in areas like caries detection and implant planning, there are genuine workforce and patient-relationship questions to work through. The Dental AI space will keep moving fast. Practices that build internal literacy now — understanding what “FDA-cleared” means, what validation looks like, how to read an accuracy claim — will be far better positioned to make good decisions than those waiting for a single consensus recommendation.
Start with your imaging workflow. That’s where the evidence is strongest and where cleared tools are most widely available. If you haven’t evaluated what your current radiograph workflow is missing, that’s the right first question.
Frequently asked questions
How many FDA-cleared AI tools exist for dental imaging in 2025?
A 2025 narrative review identified 13 companies offering 29 FDA-cleared AI products for dental imaging. These cover a range of tasks including caries detection, periodontal disease assessment, cephalometric analysis, multi-pathology diagnostics, automated dental charting, and 3D segmentation. Most cleared the FDA via the 510(k) Premarket Notification pathway for moderate-risk devices.
Is dental AI accurate enough to trust clinically?
For radiographic caries and periodontal disease detection, peer-reviewed systematic reviews document high accuracy on panoramic radiographs, with some studies reporting figures exceeding 90% — though results vary by dataset, imaging hardware, and patient population. According to VideaHealth's own published data, their platform reduced missed caries lesions by 43% and incorrect diagnoses by approximately 15%. FDA clearance and independent validation data remain the most reliable indicators of real-world performance.
What does the new ADA AI standard (ANSI/ADA 1110-1:2025) actually require?
ANSI/ADA Standard No. 1110-1:2025, approved in early 2025, sets standardized criteria for how 2D radiograph data should be annotated and collected when used to train or validate AI clinical decision-support tools. It doesn't mandate which products practices must use — it establishes a common methodology so that accuracy claims from different vendors can eventually be compared on equal terms.
Should a general dental practice adopt AI diagnostic tools now, or wait?
For radiographic diagnostics specifically, the evidence is mature enough to justify evaluation now — particularly if your practice has consistent digital imaging workflows. Focus on FDA-cleared tools with published, independent validation data and check that integration with your existing imaging software is confirmed before purchasing. For generative AI applications like crown design or automated charting, the technology is promising but most use cases are still evolving; a wait-and-see approach for those specific tools is reasonable.
Sources
- 1.Diagnostic Support in Dentistry Through Artificial Intelligence: A Systematic Review — PMC
- 2.FDA-Approved AI Solutions in Dental Imaging: A Narrative Review — PMC
- 3.What Are the Standards for AI Use in Dentistry? — American Dental Association
- 4.DentalMonitoring Enhances Orthodontic Software With FDA De Novo AI — Dentistry Today
The Digital Dentistry editorial team covers dental technology for practice owners, clinicians and dental labs. Our articles are produced with AI assistance under human editorial governance, fact-checked against cited primary sources, and updated as products and evidence change. See our editorial policy for how we work and how to flag a correction.